|Fellows Academic Contributions|
Publications:Amitkumar Mehta, MD
Mehta A, Rangarajan S, and Borate, U. A cautionary tale for probiotic use in hematopoietic SCT patients-Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplant. 2012 Aug 13. doi: 10.1038/bmt.2012.153. [Epub ahead of print]
Amitkumar Mehta, MD
Hossain M, Borate U, Mehta A, Pressey C, Jukkola-Vuorinen A, Tuomela J, Selander K, Graves D, and Harris, KW. Extracellular telomeres can be detected in serum following cellular apoptosis in vitro and after cancer chemotherapy in AML patients [abstract]. Presented at: 15th Annual Research Retreat of the UAB Comprehensive Cancer Center; 2012, October 29; Birmingham, AL.
Posters:Amitkumar Mehta, MD
Mehta A, Reddy V, and Borate U. Anti CD-30 antibody-drug conjugate brentuximab vedotin (ADCETRIS®) may be a promising treatment option for Systemic Mastocytosis (SM). Poster session presented at: 54th Annual Conference of the American Society of Hematology (ASH); 2012, December 8-11; Atlanta, GA.
Mehta A, Sonpavde G, Maughan B, Boucher KM, Fougeray R, Choueiri TK, Niegisch G, Wong YN, Sridhar SS, Sternberg CN,
Bellmunt J. External validation of the association of progression-free survival at 6 months (PFS6) with overall survival at 12 months (OS
12) in second-line therapy for advanced urothelial carcinoma (UC). Poster session presented at: 15th Annual Research Retreat of the UAB Comprehensive Cancer Center; 2012, October 29; Birmingham, AL.
Awards:Amitkumar Mehta, MD
Dr. Mehta received a travel grant from the American Society for Blood and Marrow Transplantation (ASBMT) to help offset the cost of attending their 2013 BMT Tandem Meetings which will be held on Feb. 13-17 at the Salt Palace Convention Center in Salt Lake City, UT.